GRCL
Gracell Biotechnologies Inc.
485.20$
-2.8%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +147.5% | -4.0% | -4.1% | -6.2% | -6.2% | -1.8% | -3.2% | -9.9% | -11.0% | -6.5% | +37.2% | |
| – | +172.8% | -4.8% | -4.6% | -6.6% | -6.6% | -1.2% | -4.0% | -10.4% | -11.4% | -5.8% | +42.2% | |
| – | +186.1% | -5.0% | -4.7% | -6.4% | -11.4% | -5.3% | -6.8% | +1.6% | -12.4% | -112.4% | – | |
| – | +180.6% | -5.3% | -4.7% | -6.4% | -7.5% | +0.7% | -4.6% | -10.5% | -12.4% | -7.0% | +43.8% | |
| – | +0.0% | – | – | – | +0.0% | -75.7% | – | – | +0.0% | -100.0% | – | |
| – | +0.0% | – | – | – | +0.0% | +147.8% | – | – | – | – | – | |
| – | +20.8% | +12.4% | -3.4% | -1.7% | -6.1% | -9.5% | +14.9% | -3.5% | – | – | – | |
| – | +33.3% | +13.1% | +1.0% | +5.2% | +12.0% | +9.5% | +9.1% | -9.9% | -6.2% | -8.3% | +11.5% | |
| – | +29.6% | +9.0% | +4.1% | +13.0% | +20.6% | +16.0% | +13.6% | -10.5% | -4.1% | -8.4% | +18.4% | |
| – | +51.3% | -1.1% | -0.4% | +13.2% | +22.1% | +15.8% | +20.8% | -11.4% | +5.0% | -15.4% | -30.3% | |
| – | – | – | – | – | +0.0% | – | – | – | – | – | – | |
| – | +0.0% | +7.2% | +0.0% | -2.3% | +0.0% | -2.6% | -9.1% | -3.4% | -10.3% | -4.2% | -16.1% | |
| – | +167.7% | -5.5% | -4.7% | -7.5% | -8.5% | -3.5% | -5.4% | -9.9% | -12.0% | -6.1% | +42.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -80.0% | +10.4% | +0.1% | +388.7% | -79.4% | +0.1% | +0.0% | +400.1% | -80.0% | +0.8% | +22.9% |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.